Human TRAILR1/TNFRSF10A Antibody, R&D Systems™

TRAILR1/TNFRSF10A

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

APO2, CD261, CD261 antigen, cytotoxic TRAIL receptor, Death receptor 4, DR4, DR4 TRAIL receptor 1, TNF-related apoptosis inducing ligand receptor 1, TNF-related apoptosis-inducing ligand receptor 1, TNFRSF10A, TRAIL R1, TRAIL-R1, TRAILR-1, TRAILR1MGC9365, tumor necrosis factor receptor superfamily member 10A, tumor necrosis factor receptor superfamily, member 10a

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

8797

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Flow Cytometry, Immunohistochemistry, CyTOF

69036

Flow Cytometry 2.5 ug/10^6 cells, Immunohistochemistry 1-25 ug/mL, CyTOF-ready

AAC51226

TNFRSF10A

S. frugiperdainsect ovarian cell lineSf21-derived recombinant human TRAIL R1/TNFRSF10A Ala24-Asn239 Accession # AAC51226

25 μg

Primary

Detects recombinant human TRAIL R1/TNFRSF10A in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) TRAIL R2, rhTRAIL R3, rhTRAIL R4, or rhDcR3 is observed.

Human

Purified